M
Maria Ermelinda Camilo
Researcher at Instituto de Medicina Molecular
Publications - 93
Citations - 6514
Maria Ermelinda Camilo is an academic researcher from Instituto de Medicina Molecular. The author has contributed to research in topics: Randomized controlled trial & Cancer. The author has an hindex of 37, co-authored 93 publications receiving 6049 citations. Previous affiliations of Maria Ermelinda Camilo include University of Lisbon.
Papers
More filters
Journal ArticleDOI
Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing Radiotherapy
TL;DR: During radiotherapy, both interventions positively influenced outcomes; dietary counseling was of similar or higher benefit, whereas even 3 months after RT, it was the only method to sustain a significant impact on patient outcomes.
Journal ArticleDOI
Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy
TL;DR: This study aimed to determine the effect of dietary counseling or oral supplements on outcome for patients with cancer, specifically, nutritional outcome, morbidity, and quality of life (QOL) during and 3 months after radiotherapy.
Journal ArticleDOI
Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease
Rita Castro,Isabel Rivera,Eduard A. Struys,Erwin E.W. Jansen,Paula Ravasco,Maria Ermelinda Camilo,Henk J. Blom,Cornelis Jakobs,Isabel Tavares de Almeida +8 more
TL;DR: Global DNA methylation may be altered in vascular disease, with a concomitant increase in plasma tHcy and AdoHcy.
Journal ArticleDOI
Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
Paulo S Ribeiro,Helena Cortez-Pinto,Susana Solá,Rui E. Castro,Rita M. Ramalho,Amélia Baptista,Miguel Carneiro de Moura,Maria Ermelinda Camilo,Cecília M. P. Rodrigues +8 more
TL;DR: Liver injury in NASH and ASH is associated with increased hepatocyte apoptosis mediated by death receptors, and this potential mechanistic link might provide multiple interesting targets for therapeutic intervention.
Journal ArticleDOI
Cancer: disease and nutrition are key determinants of patients’ quality of life
TL;DR: Although cancer stage was the major determinant of patients’ QoL globally, there were some diagnoses for which the impact of nutritional deterioration combined with deficiencies in nutritional intake may be more important than the stage of the disease process.